Walter W. Offen
Research Fellow, Eli Lilly and Company
Walter W. Offen, PhD, Research Fellow, Eli Lilly and Company, has more than 20 years of experience in clinical trials for numerous therapeutic areas. He led a development team at Lilly to create a SAS-based analysis system for clinical trials, which is still in use today. He has been involved with Pharmaceutical Research and Manufacturers of America (PhRMA) and participated in or led several PhRMA expert teams.
By This Author
Analysis of Clinical Trials Using SAS®: A Practical Guide
By Alex Dmitrienko, Geert Molenberghs, Christy Chuang-Stein, and Walter Offen
This comprehensive guide bridges the gap between statistical methodology and real-world clinical trial applications. Topics reflect the International Conference on Harmonization (ICH) guidelines for the pharmaceutical industry and address important statistical problems encountered in clinical trials.
*Replaced by a new edition, Analysis of Clinical Trials Using SAS®: A Practical Guide, Second Edition
2006-2007 Society for Technical Communication, International: Technical Art Competition:
Analysis of Clinical Trials Using SAS: A Practical Guide
Award of Excellence - Cover Design
- Tricia Aanderud is Senior Director of the Data Visualization Practice at Zencos.
- Robert Carver is a senior lecturer at the International Business School at Brandeis University in Waltham, Massachusetts. Prior to his retirement, he was also Professor of Business Administration at Stonehill College in Easton, Massachusetts.
- Jane Eslinger is a SAS Certified Advanced Programmer for SAS 9 and a SAS Certified Advanced Visual Business Analyst.
- Gerhard Svolba, Ph.D. is a product manager and pre-sales consultant at SAS Institute Inc. in Austria, where he specializes in Analytics and customer intelligence